Together, We Can End the War on Drugs

Our work would not be possible without your support. Invest in a more sensible future by making your tax-deductible donation to SSDP today!
DONATE

SSDP Community Hangouts are Open to All

Community matters at SSDP, and that is why we are hosting monthly "SSDP Hangouts" for the SSDP family to get together to share upcoming projects, seek advice, and meet like-minded leaders. What to expect at a SSDP virtual hangout: Share upcoming thoughts about the upcoming election Learn about projects led ...
/ / Blog

SSDP Science Policy Committee successfully pushes back on DEA effort to criminalize psychedelic research

FOR IMMEDIATE RELEASE: SSDP Science Policy Committee successfully pushes back on DEA effort to criminalize psychedelic research On Friday August 26, 2022, the Drug Enforcement Administration (DEA) withdrew proposed Schedule I status for 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). The notice states that “The Drug Enforcement Administration (DEA) is withdrawing a ...
/ / Press Releases

Countdown For Cannabis Clemency

Two years ago today, SSDP and Last Prisoner Project joined forces to mobilize a rally in Washington D.C. for cannabis justice. Our goal then (and now) is to keep reminding the President of his campaign promise to release cannabis prisoners and provide them with retroactive relief. While this administration has ...
/ / Blog

Meet the Legal Team Fighting the DEA to Save Psychedelic Research – Psychedelics Today

We are grateful to Psychedelics Today for educating the community about the importance of DOI & DOC. “I have many colleagues who work with these compounds who will testify in the upcoming hearing, and that is only a subset of the research community,” said Elijah Ullman, Chair of SSDP's Science ...
/ / News

DEA Faces Setback As Judge Denies Request To Block Witnesses In Psychedelics Ban Hearing – Benzinga

In a significant development for psychedelics research, a Drug Enforcement Administration (DEA) administrative law judge has rejected the agency's request to block key witnesses and evidence in an upcoming hearing. The case, set for November, challenges the DEA's proposed ban on two psychedelic compounds, DOI and DOC, which are used in research. Thank you to Benzinga ...
/ / News

Looking Ahead to Psychedelic Science 2025 in Denver next June

SSDP is proud to serve as a community partner for MAPS Psychedelic Science, taking place June 16-20, 2025 at the Colorado Convention Center in Denver. In 2023, Psychedelic Science hosted over 12,000 guests and was the largest psychedelic gathering in the world with classes and workshops, 10 educational stages, expo ...
/ / Blog

DEA Judge Denies Agency’s Request To Block Witnesses In Hearing Challenging Proposed Psychedelics Ban – Marijuana Moment

“Science prevails!” SSDP Executive Director Kat Murti told Marijuana Moment on Monday. “The DEA is trying to force medical research into the dark ages by criminalizing DOI and DOC—essential research chemicals in pre-clinical psychiatry and neurobiology whose status as unscheduled compounds has made them de facto tools for researchers studying ...
/ / News

The Importance of Language and Cannabis Reform

We all know that words matter, but can the way we speak about a plant have legal implications? SSDP appointed board member and Prop 19 alum Evan Nison believes so, and broaches this important topic in a recent article he wrote that was published in Legal Reader. The article reflects ...
/ / Blog

Introducing SSDP’s Yes on 4 Campaign Educators

Yes on 4, The Natural Psychedelic Substances Act, is a citizen-led ballot question that will enable therapeutic access to natural psychedelic medicines that show promise in treating mental health conditions in Massachusetts. The measure creates a regulated framework for supervised use with trained facilitators at licensed psychedelic therapy centers and ...
/ / Blog

Sign Up to Support SSDP and Science at Historic Public Hearing on DOI and DOC

SSDP is leading the fight to keep psychedelic research legal! The DEA wants to add two important research chemicals—2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC)—to Schedule I of the Controlled Substances Act, despite decades of safe usage in labs and no history of abuse. DOI and DOC’s current status as unscheduled compounds ...
/ / Blog

Investors Hangout: DEA Witness Denial Sparks Outcry Among Advocates

Published on October 7, 2024 in Investors Hangout by Owen Jenkins. The Drug Enforcement Administration (DEA) has caused quite a stir by denying testimony from important witnesses just before scheduled hearings on the potential classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). This decision has led to significant backlash ...
/ / News

Benzinga: DEA Rejects Witnesses For November Hearings On Two Psychedelic Compounds, Advocates Push Back

Coverage on October 7, 2024 in Benzinga by Juan Spínelli. “What is the DEA so scared of that these leading scientists must be muzzled?” asked Robert Rush, a Denver-based attorney representing SSDP. He criticized the agency for attempting to block testimony from some of the world’s foremost experts in neuroscience and ...
/ / News

Green Market Report: DEA rejects speakers for November hearings on two psychedelic compounds

We are grateful to Debra Borchardt from Green Market Report for her coverage on the DOI/DOC hearings published on October 4, 2024. “What is the DEA so scared of that these leading scientists must be muzzled?” said Robert Rush, a Denver-based attorney who is working hand-in-hand with SSDP to keep ...
/ / News

Filter: DEA Bids to Exclude Expert Witnesses From Psychedelics-Ban Hearing

Special thanks to Jack Gorsline from Filter Magazine for a deeper look into the DEA's response to our expert witnesses for the DOI and DOC hearing. Published on October 4, 2024. “We have assembled a world-class international group of behavioral and molecular pharmacologists, chemists, neuroscientists, and a former Government Advisor on ...
/ / News

Marijuana Moment: DEA Seeks To Block Experts From Giving ‘Incompetent’ Testimony At Hearing On Proposed Psychedelics Ban

DOI and DOC’s current status as unscheduled compounds has made them de facto tools for researchers studying serotonin receptors. They have featured in more than 900 research articles and show promise for pain management, combatting anxiety and depression, and preventing overdose. Scheduling DOI and DOC would create serious impediments to ...
/ / News

DEA SILENCES SCIENTISTS; STUDENT GROUP PUSHES BACK AGAIN

Contact:Gina Giorgio Director of Strategy and DevelopmentStudents for Sensible Drug Policygina@ssdp.org DEA SILENCES SCIENTISTS; STUDENT GROUP PUSHES BACK AGAIN Since 2022, Students for Sensible Drug Policy (SSDP) Has Led the Fight to Prevent the DEA From Scheduling DOI and DOC, Which Would Create Serious Impediments to Potentially Life-Saving Research [Washington D.C., ...
/ / Press Releases

SSDP Partners with Overdrive Defense To Make Drug Checking Cool

Over 100,000 people died from overdose in the United States last year. Many of these overdoses were caused by Fentanyl, a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine that has exacerbated the overdose epidemic caused by the War on Drugs ...
/ / Blog

Meet Deandré Smith, SSDP’s New Director of Chapter Relations and Strategic Expansion 

SSDP is pleased to welcome Deandré Smith as our new Director of Chapter Relations and Strategic Expansion. Deandré has experienced SSDP through many different lenses—as an SSDP Ambassador at Florida Agricultural and Mechanical University (FAMU), where he is a Doctor of Pharmacy candidate, as an alum of SSDP's HBCU Ambassador ...
/ / Blog
Join SSDP’s New Drug Education Committee

Shape the Future of Drug Education With SSDP

We are excited to announce our new Drug Education Committee, and are looking for passionate and skilled individuals to join us in shaping the future of drug education and harm reduction on college campuses and in school systems nationwide! Apply to Join What We’re Doing: By joining the SSDP Drug ...
/ / Blog, Education

SSDP Features in The Microdose

The Microdose is an independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics with over 45,000 subscribers Scheduling DOI and DOC would create serious impediments to potentially life-saving research, and yet SSDP is the only drug policy organization currently fighting to keep DOI and DOC ...
/ / News

We do this work because the war on drugs is a war on us.

Sign up today to receive periodic updates!